That came out of left field! However, that is a great development for ePAT/MNQ as it opens up a whole new market and hence multiple new streams of potential revenue. Having multiple streams of potential revenue is a good risk mitigation strategy as well. I wonder if the ePAT App is going to be used in this industry whether it will need FDA and TGA approval for this particular application? If not it may mean that getting a commercial version for use in the insurance industry might be a faster way to cash flow.
MNQ Price at posting:
1.7¢ Sentiment: None Disclosure: Held
